DNMT1 and neoplasm: Over-expression of DNMTs has been described in several human tumour types, including lymphomas, liver, prostate, colorectal, breast, lung, pancreatic and endometrial cancer [13–18], and is generally associated with a more aggressive phenotype, indicating that DNMT1, 3A and 3B likely act as oncogenes [19].